CERT
Certara (CERT)
$23
About Certara (CERT)
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Details
Daily high
$7.50
Daily low
$7.16
Price at open
$7.39
52 Week High
$15.69
52 Week Low
$7.16
Market cap
1.2B
Dividend yield
0.00%
Volume
5.1M
Avg. volume
2.2M
P/E ratio
109.50
Certara News
Details
Daily high
$7.50
Daily low
$7.16
Price at open
$7.39
52 Week High
$15.69
52 Week Low
$7.16
Market cap
1.2B
Dividend yield
0.00%
Volume
5.1M
Avg. volume
2.2M
P/E ratio
109.50